A166
Phase 1- Indications
- HER2-positive breast cancer
Company intelligence / Profile preview
Levena Biopharma
San Diego, California, United States
- Ownership
- Private
- Employees
- ~58
- Development stage
- Phase 1
01
Overview
Levena Biopharma specializes in the design, synthesis, analytical characterization, process development, scale-up and cGMP manufacturing of antibody-drug conjugates using proprietary linkers/payloads and site-specific conjugation technologies. Their technology has enabled clinical candidates such as A166—a third-generation anti-HER2 ADC—demonstrating antitumor activity in heavily pretreated HER2-positive breast cancer patients.
- Therapeutic areas
- Oncology
- Modalities
- Antibody-drug conjugateAntibody fusion proteinSmall molecule (as payloads for ADCs)Peptides (as payloads for ADCs)Protein (as part of ADC structure)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
NavrogenSichuan Kelun-Biotech
Beyond the preview
Go deeper on Levena Biopharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Levena Biopharma.